Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
Article first published online: 21 MAR 2014
© 2014 The Authors. Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Acta Psychiatrica Scandinavica
Volume 130, Issue 3, pages 163–180, September 2014
How to Cite
Effects of oxidative stress on fatty acid and one-carbon metabolism in psychiatric and cardiovascular disease comorbidity., , , , , .
Please see editorial comment to this paper by M.J. McCarthy in this issue, Acta Psychiatr Scand 2014;130:161-162.
- Issue published online: 18 AUG 2014
- Article first published online: 21 MAR 2014
- Manuscript Accepted: 20 FEB 2014
- NWO/ZonMW. Grant Number: 016.126.059
- cardiovascular disease;
- fatty acids;
- oxidative stress;
Cardiovascular disease (CVD) is the leading cause of death in severe psychiatric disorders (depression, schizophrenia). Here, we provide evidence of how the effects of oxidative stress on fatty acid (FA) and one-carbon (1-C) cycle metabolism, which may initially represent adaptive responses, might underlie comorbidity between CVD and psychiatric disorders.
We conducted a literature search and integrated data in a narrative review.
Oxidative stress, mainly generated in mitochondria, is implicated in both psychiatric and cardiovascular pathophysiology. Oxidative stress affects the intrinsically linked FA and 1-C cycle metabolism: FAs decrease in chain length and unsaturation (particularly omega-3 polyunsaturated FAs), and lipid peroxidation products increase; the 1-C cycle shifts from the methylation to transsulfuration pathway (lower folate and higher homocysteine and antioxidant glutathione). Interestingly, corresponding alterations were reported in psychiatric disorders and CVD. Potential mechanisms through which FA and 1-C cycle metabolism may be involved in brain (neurocognition, mood regulation) and cardiovascular system functioning (inflammation, thrombosis) include membrane peroxidizability and fluidity, eicosanoid synthesis, neuroprotection and epigenetics.
While oxidative-stress-induced alterations in FA and 1-C metabolism may initially enhance oxidative stress resistance, persisting chronically, they may cause damage possibly underlying (co-occurrence of) psychiatric disorders and CVD. This might have implications for research into diagnosis and (preventive) treatment of (CVD in) psychiatric patients.